| 000 | 01779 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513144332.0 | ||
| 264 | 0 | _c19980709 | |
| 008 | 199807s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm970513p _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaw, H | |
| 245 | 0 | 0 |
_aBenzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cJun 1998 |
||
| 300 |
_a2243-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-Agonists _xchemical synthesis |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 |
_aCyclic AMP _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIsometric Contraction _xdrug effects |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aOxymetazoline _xanalogs & derivatives |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aReceptor, Serotonin, 5-HT1B |
| 650 | 0 | 4 | _aReceptor, Serotonin, 5-HT1D |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Serotonin _xdrug effects |
| 650 | 0 | 4 |
_aSaphenous Vein _xdrug effects |
| 650 | 0 | 4 |
_aSerotonin Receptor Agonists _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aDukat, M | |
| 700 | 1 | _aTeitler, M | |
| 700 | 1 | _aLee, D K | |
| 700 | 1 | _aMazzocco, L | |
| 700 | 1 | _aKamboj, R | |
| 700 | 1 | _aRampersad, V | |
| 700 | 1 | _aPrisinzano, T | |
| 700 | 1 | _aGlennon, R A | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 41 _gno. 13 _gp. 2243-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm970513p _zAvailable from publisher's website |
| 999 |
_c9598689 _d9598689 |
||